Literature DB >> 33830411

Uterine synechiae after intrauterine device use: a case series.

Mary Kathryn Abel1,2, Kaitlyn Wald3, Marcelle I Cedars3, Martha Noel3.   

Abstract

PURPOSE: The intrauterine device (IUD) is one of the most effective and safe contraceptive methods. Substantial literature suggests an overall return to normal fertility following IUD removal. However, there are no studies to date that evaluate endometrial function specifically in nulliparous women after levonorgestrel IUD use.
METHODS: We present three nulliparous women with a history of levonorgestrel IUD use who were evaluated for uterine dysfunction at the University of California, San Francisco Center for Reproductive Health. These patients had no other known risk factors or history of uterine manipulation, including prior uterine surgery, pelvic radiation, intrauterine infection, hypothalamic amenorrhea, or uterine anomaly.
RESULTS: Upon evaluation, these patients were found to have uterine synechiae concerning for Asherman syndrome. All three patients were eventually able to conceive through assisted reproductive technology or natural conception.
CONCLUSION: This case series is the first to suggest a possible effect of endometrial dysfunction on fertility resumption following levonorgestrel IUD removal in nulliparous patients. It is possible that a small subset of patients may be at risk for Asherman syndrome after IUD use. Larger prospective trials are needed to explore this possible association.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Asherman syndrome; Infertility; Intrauterine adhesions; Intrauterine device

Mesh:

Substances:

Year:  2021        PMID: 33830411      PMCID: PMC8581113          DOI: 10.1007/s10815-021-02173-6

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.357


  20 in total

Review 1.  Morphological and functional changes in human endometrium following intrauterine levonorgestrel delivery.

Authors:  R L Jones; H O Critchley
Journal:  Hum Reprod       Date:  2000-08       Impact factor: 6.918

2.  Endometrial morphology during long-term use of levonorgestrel-releasing intrauterine devices.

Authors:  S G Silverberg; M Haukkamaa; H Arko; C G Nilsson; T Luukkainen
Journal:  Int J Gynecol Pathol       Date:  1986       Impact factor: 2.762

3.  Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years' comparative experience of levonorgestrel- and copper-releasing intrauterine devices.

Authors:  J Toivonen; T Luukkainen; H Allonen
Journal:  Obstet Gynecol       Date:  1991-02       Impact factor: 7.661

4.  Historical record-setting trends in IUD use in the United States.

Authors:  David Hubacher; Megan Kavanaugh
Journal:  Contraception       Date:  2018-05-26       Impact factor: 3.375

5.  Practice Bulletin No. 186: Long-Acting Reversible Contraception: Implants and Intrauterine Devices.

Authors: 
Journal:  Obstet Gynecol       Date:  2017-11       Impact factor: 7.661

6.  Declines in Unintended Pregnancy in the United States, 2008-2011.

Authors:  Lawrence B Finer; Mia R Zolna
Journal:  N Engl J Med       Date:  2016-03-03       Impact factor: 91.245

Review 7.  Insulin-like growth factors and insulin-like growth factor binding proteins in the endometrium. Effect of intrauterine levonorgestrel delivery.

Authors:  E M Rutanen
Journal:  Hum Reprod       Date:  2000-08       Impact factor: 6.918

Review 8.  Contraceptive failure in the United States.

Authors:  James Trussell
Journal:  Contraception       Date:  2011-03-12       Impact factor: 3.375

9.  Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery.

Authors:  H O Critchley; H Wang; R L Jones; R W Kelly; T A Drudy; A E Gebbie; C H Buckley; A S McNeilly; A F Glasier
Journal:  Hum Reprod       Date:  1998-05       Impact factor: 6.918

10.  Contraceptive method use in the United States: trends and characteristics between 2008, 2012 and 2014.

Authors:  Megan L Kavanaugh; Jenna Jerman
Journal:  Contraception       Date:  2017-10-13       Impact factor: 3.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.